Revista Mexicana de Patología Clínica y Medicina de Laboratorio

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Revista Mexicana de Patología Clínica y Medicina de Laboratorio >Year 2005, Issue 4

Zamora PA, Sánchez GJC
When the laboratory is not in agreement with the clinic. Hepatitis B
Rev Mex Patol Clin Med Lab 2005; 52 (4)

Language: Español
References: 10
Page: 234-239
PDF: 104.40 Kb.

Full text


For most of the Clinical Laboratory and Blood Bank professionals it is quite common to receive comments in order to explain a lab result that seems not to be in accordance with the patient’s condition. A frequent case, for instance, is related to the interpretation of Hepatitis B immunological profile, where it should be emphasized that this diagnosis must be done through the utilization of several contributory tests. In consequence, it is impossible to establish the clinical condition of the patient or the integral diagnosis with a single determination. In this document, important issues related to the viral structure of recently reported and understood mutant strains are discussed, including the natural history of acute and chronic Hepatitis B, the sequential appearance in blood of viral antigens and related capsid and core antibodies and their clinical relevance, plus the characteristics of immunological tests and possible causes for false positive and negative results. Finally, some recommendations are expressed in order to support clinical correlation with the etiological and psychopathological diagnosis of Hepatitis B.

Key words: Hepatitis B, HbsAg, diagnosis.


  1. Dienstag JL, Isselbacher KJ. Hepatitis viral aguda. En: Harrison. Tratado de Medicina Interna 14 edición. Mc Graw-Hill. 1998: 1904-1909.

  2. Tenover FC, Yolken RH (eds). Manual of Clinical Microbiology. 7ª ed. Washington: ASM Press 1999: 1025-1042.

  3. Liu Z, Luo K, He H, Hou, (2005). Hot-spot mutation in hepatitis B virus core gene: eliciting or evading immune clearance? Journal of Viral Hepatitis 2005; 12(2): 146-153.

  4. Zuckerman JN, Zuckerman AI. Mutations of the surface protein of hepatitis B virus. Antiviral Res 2003; 60: 75-78.

  5. Diagnóstico serológico de la hepatitis B. En:

  6. www.microbiologiaclinica.com/diaghepb.htm

  7. Alhababi F, Sallam TA, Tong CY. The significance of ‘anti-HBc only‘ in clinical virology laboratory. J Clin Virol 2003; 27(2): 162-9.

  8. Navarro OD, García DA. Diagnóstico de la infección por el virus de la hepatitis B: Reactividad aislada del antígeno de superficie. En: http//seimc.org/control/revi_Serfo/HBsAg.htm

  9. Cameron SO, Stewart J, Davidson M, Ho-Yen D. Problems of an automated testing system for hepatitis B. Comm Dis Public Health 2000; 3: 141-142.

  10. Ratnam S, Stead F, Head CB. False-positive results with third-generation monoclonal hepatitis B surface antigen enzyme immunoassay. J Clin Microbiol 1989; 27: 2102-2104.

  11. Pan CQ, Zhang JX. Natural history and clinical consequences of hepatitis B viral infection. Int J Med Sci 2005; 2(1).

>Journals >Revista Mexicana de Patología Clínica y Medicina de Laboratorio >Year 2005, Issue 4

· Journal Index 
· Links 

Copyright 2019